Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.48 |
| ▸ | FAAH | O00519 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9664622 | 1.00 | SLC6A5 (0.53) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL9665935 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL19138227 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL17203886 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL19138207 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL19138238 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL13279668 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL9664371 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL20956613 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH | |
| SCHEMBL9664377 | 0.99 | SLC6A5 (0.54) | SLC6A5NOD1ITGB3ITGA2BFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| US-20250339370-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AVANTOR PERFORMANCE MATERIALS, LLC (US) | 2025-11-06 | — | — | US | disclosed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| CN-115813794-A | Method for improving hair quality by improving scalp health | 宝洁公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-2972324-B1 | A NONINVASIVE METHOD FOR DIAGNOSING A DANDRUFF CONDITION | PROCTER & GAMBLE (US) | 2020-04-22 | — | — | EP | disclosed |
| US-20160346184-A1 | METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | THE PROCTER & GAMBLE COMPANY | 2016-12-01 | — | — | US | disclosed |
| EP-2972324-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | The Procter & Gamble Company (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20140273055-A1 | NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN: OXIDATIVE STRESS AND OXIDATIVE DAMAGE BIOMARKERS | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014144265-A1 | A NONINVASIVE METHOD FOR MEASURING OXIDATIVE STRESS AND OXIDATIVE DAMAGE FROM SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339370-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AADAT, KYNU, PNISR | SLC6A5 3122/4885NOD1 3917/4885ITGB3 3803/4885 |
| US-20160346184-A1 | METHOD OF IMPROVING HAIR QUALITY BY IMPROVING SCALP HEALTH | GPX4, GPX1, COXFA4L2 | SLC6A5 4609/4885NOD1 4840/4885ITGB3 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.